Lisa Sammaritano, MD, discusses data on pregnancy outcomes during COVID-19 and how rheumatologists can advise their pregnant patients with rheumatic disease during the ongoing pandemic.
Authors of a systematic review assessed the quality of consensus-based rheumatology recommendations and identified the types and extent of pharmaceutical industry involvement.
The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
Researchers investigated the cause of dyspnea in individuals with long-haul COVID and also screened the patients for myalgic encephalomyelitis/chronic fatigue syndrome.
Using data from the COVAX physician-reported registry, researchers studied the safety of SARS-CoV-2 vaccines in patients with inflammatory/autoimmune rheumatic and musculoskeletal diseases.
In a prospective cross-sectional study, researchers investigated an involvement of the visual pathway in patients with chronic inflammatory demyelinating polyneuropathy.
Full COVID-19 vaccination status is associated with a reduced risk for breakthrough infection, while persons with immune dysfunction have an increased risk for breakthrough infection.
Among older individuals, hip fracture surgery volumes were generally lower during the COVID-19 pandemic than two years earlier until the COVID-19 vaccine became available.
In an evidence-based clinical practice guideline issued by the American Academy of Orthopaedic Surgeons, updated recommendations are presented for the management of patients with hip fracture.
